At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4 enrolled
Drug / intervention
aspirindrug
Likely dose
aspirin 81 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
In Brief
A clinical study evaluating aspirin for Healthy. Completed, enrolled 4 participants across 1 site.
Detailed Summary
Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
First PostedMay 2009
Primary CompletionAug 2009
TodayJul 2026
First PostedMay 12, 2009
Enrollment StartMay 1, 2009
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.1 years ago
Interventions
aspirindrug
81 mg orally daily for two weeks